underwriting

Soy Foods Associated with Decreased Risk of Death in Women with Breast Cancer

/ SupremeCmdr / Leave a comment

JAMA — Abstract: Soy Food Intake and Breast Cancer Survival, December 9, 2009, Shu et al. 302 (22): 2437

Design, Setting, and Participants The Shanghai Breast Cancer Survival Study, a large, population-based cohort study of 5042 female breast cancer survivors in China. Women aged 20 to 75 years with diagnoses between March 2002 and April 2006 were recruited and followed up through June 2009. Information on cancer diagnosis and treatment, lifestyle exposures after cancer diagnosis, and disease progression was collected at approximately 6 months after cancer diagnosis and was reassessed at 3 follow-up interviews conducted at 18, 36, and 60 months after diagnosis. Annual record linkage with the Shanghai Vital Statistics Registry database was carried out to obtain survival information for participants who were lost to follow-up. Medical charts were reviewed to verify disease and treatment information.

Conclusion Among women with breast cancer, soy food consumption was significantly associated with decreased risk of death and recurrence.

Tofu anyone?

Byetta (exenatide) – Renal Failure Too

/ SupremeCmdr / Leave a comment

Byetta (exenatide) – Renal Failure

From April 2005 through October 2008, FDA received 78 cases of altered kidney function (62 cases of acute renal failure and 16 cases of renal insufficiency), in patients using Byetta. Some cases occurred in patients with pre-existing kidney disease or in patients with one or more risk factors for developing kidney problems.

Oops.

CRP Meta-Analysis

/ SupremeCmdr / Leave a comment

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis : The Lancet

CRP concentration has continuous associations with the risk of coronary heart disease, ischaemic stroke, vascular mortality, and death from several cancers and lung disease that are each of broadly similar size. The relevance of CRP to such a range of disorders is unclear. Associations with ischaemic vascular disease depend considerably on conventional risk factors and other markers of inflammation.

BNP and NT-proBNP Predicts HF in Older Patients

/ SupremeCmdr / Leave a comment

Medical News: Peptide Predicts Heart Failure in Older Patients – in Cardiovascular, CHF from MedPage Today

The researchers identified 190 pg/mL as the NT-proBNP threshold for increased risk. Among study participants with baseline levels less than 190 pg/mL, an increase greater than 25% to a level above 190 pg/mL had a twofold increased risk of heart failure (HR 2.13, 95% CI 1.68 to 2.71) and cardiovascular death (HR 1.91, 95% CI 1.43 to 2.53) compared with participants whose NT-proBNP levels remained below 190 pg/mL.

Among study participants with elevated baseline NT-proBNP levels, an increase greater than 25% also doubled the risk of heart failure (HR 2.06, 95% CI 1.56 to 2.72) and cardiovascular disease (HR 1.88, 95% CI 1.37 to 2.57).

Fatty Liver Matters

/ SupremeCmdr / Leave a comment

Please tell me you already knew this.

Medical News: Fatty Liver Raises Risk of Death – in Gastroenterology, General Hepatology from MedPage Today

People with non-alcoholic fatty liver disease (NAFLD), a condition that often accompanies obesity and type 2 diabetes, have higher mortality rates than the general population, a new Swedish study found.

Patients with NAFLD were 69% percent more likely to die than the general Swedish population (standardized mortality ratio 1.69, 95% CI 1.24 to 2.25), according to a report in the February issue of Hepatology.

Patients with non-alcoholic steatohepatitis (NASH), a condition where fat buildup causes liver inflammation, were at 86% higher risk (95% CI 1.19 to 2.76; P=0.007).

Meridia (sibutramine hydrochloride) – Update

/ SupremeCmdr / Leave a comment

Oops.

Meridia (sibutramine hydrochloride): Follow-Up to an Early Communication about an Ongoing Safety Review

Sibutramine is not to be used in patients with a history of cardiovascular disease, including:

* History of coronary artery disease (e.g., heart attack, angina)
* History of stroke or transient ischemic attack (TIA)
* History of heart arrhythmias
* History of congestive heart failure
* History of peripheral arterial disease
* Uncontrolled hypertension (e.g., > 145/90 mmHg)